GGrantIndex
← Search

Administrative Core

$578,637P30FY2022CANIH

Johns Hopkins University, Baltimore MD

Investigators

Linked publications, trials & patents

Trial NCT02989636Trial NCT02516670Trial NCT02491411Trial NCT02489357Trial NCT02029950Trial NCT01935947Trial NCT01870596Trial NCT01783171Trial NCT01757639Trial NCT01578109Trial NCT01349972Trial NCT01349959Trial NCT01330173Trial NCT01264432Trial NCT01207726Trial NCT01207687Trial NCT01139970Trial NCT01132573Trial NCT01061749Trial NCT00971737Trial NCT00963807Trial NCT00899951Trial NCT00899548Trial NCT00898482Trial NCT00897338Trial NCT00897273Trial NCT00847171Trial NCT00795002Trial NCT00727441Trial NCT00673569Trial NCT00670917Trial NCT00660348Trial NCT00641303Trial NCT00641147Trial NCT00631137Trial NCT00616967Trial NCT00602771Trial NCT00588991Trial NCT00566098Trial NCT00524017Trial NCT00499733Trial NCT00499486Trial NCT00493025Trial NCT00492921Trial NCT00489281Trial NCT00478062Trial NCT00478010Trial NCT00471653Trial NCT00470093Trial NCT00469820Trial NCT00445484Trial NCT00433472Trial NCT00425477Trial NCT00407966Trial NCT00401024Trial NCT00389610Trial NCT00387465Trial NCT00381550Trial NCT00373191Trial NCT00369681Trial NCT00368914Trial NCT00363649Trial NCT00361296Trial NCT00356928Trial NCT00354640Trial NCT00343447Trial NCT00336063Trial NCT00334542Trial NCT00324870Trial NCT00313560Trial NCT00311623Trial NCT00305760Trial NCT00303927Trial NCT00293410Trial NCT00293397Trial NCT00293280Trial NCT00290732Trial NCT00287989Trial NCT00287872Trial NCT00281970Trial NCT00281866Trial NCT00278200Trial NCT00278161Trial NCT00278109Trial NCT00276744Trial NCT00276601Trial NCT00276588Trial NCT00274768Trial NCT00265915Trial NCT00265837Trial NCT00262834Trial NCT00258206Trial NCT00258180Trial NCT00255775Trial NCT00255710Trial NCT00245115Trial NCT00244959Trial NCT00242996Trial NCT00238368Trial NCT00238277

Abstract

PROJECT SUMMARY/ABSTRACT The Sidney Kimmel Comprehensive Cancer Center (SKCCC) Administration facilitates the SKCCC vision, mission and goals by promoting and enhancing overall planning, management and organization through a full range of administrative services. Administration provides support and guidance necessary to achieve and maintain the highest standards of excellence in cancer research at the SKCCC. This is achieved by supporting scientific activities, leveraging SKCCC resources, and bringing SKCCC science to the catchment area, the state of Maryland and beyond. SKCCC Administration provides efficient and effective administrative support to the SKCCC's Director, Senior Leaders, Research Program Leaders, Shared Resource (SR) Directors and SKCCC members. Ms. Rosalie Russell (nee Wollett) has served as Associate Director for Administration for research and academic activities at the SKCCC since 1997. She directly oversees a staff of 126, up from 76 in 2016. In fiscal year 2021, the SKCCC Administration is directly responsible for the management of $188.9 million and more than 862,400 ft2 of space. Administration coordinates all aspects of membership activities for 285 faculty members across five schools, encompassing 34 departments. SKCCC Administration has accomplished many noteworthy achievements over this grant period. Major new initiatives supported since the last renewal include: 1) facilitating development of the 2020–2025 SKCCC Strategic Plan, Innovation for Impact 2025; 2) supporting the reorganization of the SKCCC Research Programs; 3) developing the SKCCC Bloomberg~Kimmel Institute, funded by a $125 million gift for cancer immunotherapy; 4) developing the SKCCC Cancer Convergence Institute, supported by a major institutional investment of $20 million; 5) supporting the submission of grant applications that resulted in an increase of direct peer-reviewed cancer-related research funding from $66.7 million to $78.5 million between 2015–2020; 6) providing comprehensive administrative support for submission of nine multicomponent grants (e.g., UG1, UM1, U19, U54), resulting in six funded awards; 7) facilitating recruitment of 42 new Members; 8) supporting the development of the Translational Research Central Services SR into a full SR in this application and consolidating 15 SRs into twelve to better meet the needs of SKCCC Members; 9) supporting growth of the Clinical Trials Office from 146 FTE to over 200 FTE to facilitate clinical research; 10) completing the planning and occupancy of over 145,000 ft2 of space in the Skip Viragh Outpatient Cancer Building, which opened in April 2018; 11) creating CCSGe, an electronic system for the CCSG submission and the Administrative Business Center Tracking Portal for tracking of all research-related administrative service requests; 12) deploying $25.0 million over five years for new project and pilot grant opportunities; and 13) promoting research-relevant communication across the SKCCC catchment area through additional social media platforms, cancer-focused symposia and development of the Community Outreach and Engagement website.

View original record on NIH RePORTER →